Source: FeedNavigator

Bactana: US company pursues series A funding, development of novel probiotic

Improved weight gain and health are two potential benefits from a novel probiotic being developed by Bactana, says CEO.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
John Kallassy's photo - CEO of Bactana

CEO

John Kallassy

CEO Approval Rating

90/100

Read more